November 19, 2008 - IntraOp Medical Corp. announced its second German order for the Mobetron, which delivers intraoperative electron-beam radiation therapy (IOERT) to cancer patients.
The University Hospital Giessen and Marburg GmbH (Marburg), located in Marburg, Germany will be the second Mobetron installation in Germany. The first is the Strahleninstitut in Cologne.
The Mobetron reportedly enables surgeons and radiation oncologists to target the exact area that requires radiation and to deliver high doses of radiation directly to the affected tissue during the cancer surgery. The mobile, self-shielded linear accelerator can move between operating rooms with ease, avoiding the high cost of building shielded vaults to accommodate traditional linear accelerators. Key patient benefits of IOERT are said to include: lower recurrence rates, increased survival rates, shorter treatment cycles and fewer side effects.
Marburg is a leading hospital for cancer care in Germany, maintaining more than 1,000 beds and conducting nearly 15,000 operations in eighteen operating theatres each year.
Professor Engenhart-Cabilic of the department for Radio-Oncology at Marburg, commented, “We are very excited to bring the Mobetron and IOERT to Marburg. By providing this form of radiation treatment to our cancer patients, we are able to offer them the best in cancer care.”
For more information: www.intraopmedical.com


Related Content

News | Radiology Education

April 21, 2025 — On June 20, the American Society of Radiologic Technologists (ASRT) will award Life Member status to ...

Time April 21, 2025
arrow
News | Radiology Business

April 16, 2025 — According to a new report, the U.S. Radiotherapy Market is projected to reach $2.49 billion by 2030 ...

Time April 17, 2025
arrow
News | ASTRO

March 14, 2025 — Another pivotal milestone in the nation’s fight against cancer recently took place with the ...

Time March 17, 2025
arrow
News | Computed Tomography (CT)

Royal Philips recently received 510(k) clearance from the US Food and Drug Administration (FDA) for its detector-based ...

Time November 13, 2024
arrow
News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
News | Radiation Oncology

July 11, 2024 — The American Society for Radiation Oncology (ASTRO) issued the following statement from Jeff M ...

Time July 11, 2024
arrow
News | Radiation Oncology

July 9, 2024 — Insights from the latest Mordor Intelligence report, “Radiotherapy Market Size & Share Analysis - Growth ...

Time July 09, 2024
arrow
News | Prostate Cancer

July 5, 2024 — Lantheus Holdings, Inc., a leading radiopharmaceutical-focused company committed to enabling clinicians ...

Time July 05, 2024
arrow
Subscribe Now